Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine 2003 December;47(4)

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine 2003 December;47(4)

 USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES 

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):223-37

Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases

Sosabowsky J., Melendez-Alafort L., Mather S.


 USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES 

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):238-45

99mTc-Antimicrobial peptides: promising candidates for infection imaging

Lupetti A., Pauwels E. K. J., Nibbering P. H., Welling M. M.


 USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES 

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):246-55

Radiolabeled chemotactic cytokines: new agents for scintigraphic imaging of infection and inflammation

Van Eerd J. E. M., Boerman O. C., Corstens F. H. M., Oyen W. J. G.


 USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES 

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):256-69

The developing role of peptide radiopharmaceuticals in the study of chronic inflammation: new techniques for novel therapeutic options

Chianelli M., Parisella M. G., D’Alessandra C., Corsetti F., Scopinaro F., Signore A.


 USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES 

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):270-8

The role of octreotide scintigraphy in rheumatoid arthritis and sarcoidosis

Dalm V. A. S. H., Van Hagen P. M., Krenning E. P.


 USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES 

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):279-91

Non-oncologic applications of radiolabeled peptides in nuclear medicine

Knight L. C.


 USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES 

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):292-320

“Pathophysiologic mapping” of venous thromboembolism: opportunities for radiolabeled peptides

Bernarducci M. P.


 USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES 

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):321-36

Radiolabelled peptides and low molecular weight proteins in metabolic diseases

Aprile C.


 USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES 

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):337-48

Imaging cell death in vivo

Blankenberg F., Mari C., Strauss H. W.


 USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES 

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):349-61

The role of labeled Annexin A5 in imaging of programmed cell death. From animal to clinical imaging

Kietselaer B. L. J. H., Hofstra L., Dumont E. A. W., Reutelingsperger C. P. M., Heidendal G. A. K.


top of page